PEDIATRICS Vol. 82 No. 2 August 1988, pp. 229-233
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McLaughlin, M.
Right arrow Articles by Orenstein, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McLaughlin, M.
Right arrow Articles by Orenstein, W.

Live Virus Vaccines in Human Immunodeficiency Virus-Infected Children: A Retrospective Survey

Margaret McLaughlin MD, MPH1, Pauline Thomas MD1, Ida Onorato MD1, Arye Rubinstein MD1, James Oleske MD1, Stephen Nicholas MD1, Keith Krasinski MD1, Pamela Guigli MPH1, and Walter Orenstein MD1

1 From the New York City Department of Health, New York, the Division of Immunization, Centers for Disease Control, Atlanta, and physicians and hospitals in New York and Newark, New Jersey

Live virus vaccines can cause serious adverse reactions when administered to immunocompromised patients. Because children infected with human immunodeficiency virus (HIV) may be immunosuppressed, immunization of these children with live virus vaccines is a potential problem. A retrospective survey was conducted by the New York City Department of Health, with consultation from the Centers for Disease Control, to evaluate the frequency of serious adverse events following receipt of live vaccines among children with HIV infection receiving pediatric care in New York City and New Jersey. Outpatient records of 319 children being cared for by 16 participating physicians were reviewed. Of the 319 charts, 221 (69%) contained vaccination histories. Perinatal transmission of HIV infection was suspected for 208 (94%) of the 221 cases and infection via transfusion for the remaining 13 (6%). Of the 221 for whom immunization histories were available, 180 (81%) had received at least one dose of live oral polio vaccine and 70 (32%) had received measles, mumps, and rubella vaccine. There were 120 children for whom a temporal relationship between immunization and onset of symptoms of immunodeficiency could be seen; 46/120 had received at least one dose of oral polio vaccine and 23/45 had received measles, mumps, and rubella vaccine after onset of symptoms. Although follow-up of this population has been limited, there were no reports of serious adverse events such as typical or atypical measles, paralytic poliomyelitis, or aseptic meningitis in the month following vaccination. New York City Department of Health and New Jersey State Department of Health surveillance records for adverse vaccine events following immunization support these findings; no child with vaccine-associated illness was noted to have acquired immunodeficiency syndrome or related illness for the period 1979 to 1986. No evidence was noted of serious adverse reactions following receipt of live virus vaccines in HIV-infected children.

Key Words: live virus vaccine • human immunodeficiency virus infection • immunization • acquired immunodeficiency syndrome

Submitted on June 29, 1987
Accepted on November 30, 1987




This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
P. H. Dennehy
Active Immunization in the United States: Developments over the Past Decade
Clin. Microbiol. Rev., October 1, 2001; 14(4): 872 - 908.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
I. Chitsike and R. van Furth
Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: case report
BMJ, March 27, 1999; 318(7187): 841 - 843.
[Abstract] [Full Text]

Home page
 Clin. Microbiol. Rev.Home page
L.-a. Pirofski and A. Casadevall
Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host
Clin. Microbiol. Rev., January 1, 1998; 11(1): 1 - 26.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pediatric Oncology NursingHome page
D. G. Cohen
Similarities Between the Nursing Care Needs of Children with Cancer and Children With Human Immunodeficiency Virus Infection
Journal of Pediatric Oncology Nursing, January 1, 1990; 7(4): 149 - 153.
[Abstract] [PDF]

Home page
 Med Decis MakingHome page
I. M. Onorato, W. A. Orenstein, A. R. Hinman, M. F. Rogers, and J. P. Koplan
Immunization of Asymptomatic HIV-infected Children with Measles Vaccine: Assessment of Risks and Benefits
Med Decis Making, June 1, 1989; 9(2): 76 - 83.
[Abstract] [PDF]